Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00620165 · ClinicalTrials.gov registry record · Phase 1
Efficacy of Levetiracetam in Essential Tremor
A Phase 1 study, sponsored by Southern California Institute for Research and Education.
- Completed
- Registry status
- Phase 1
- Development phase
- 10
- Enrollment target
NCT00620165 is a Phase 1 study that has completed, run by Southern California Institute for Research and Education. The registered enrollment target is 10 participants.
The verdict
NCT00620165, a Phase 1 study, has completed, sponsored by Southern California Institute for Research and Education.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 10 participants
- Enrollment target
Study Summary
Essential tremor poses one of the greatest therapeutic challenges to neurologists. This study will examine the effectiveness of the drug, levetiracetam or keppra, for the treatment of essential tremor.
Interventions
- DRUG placebo
- DRUG levetiracetam
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 10 participants |
| Start Date | 2005-01 |
| Est. Completion | 2008-03 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT00620165
The ClinicalTrials.gov registry entry for NCT00620165 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 10 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Southern California Institute for Research and Education, which has 13 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT00620165 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT00620165 about?
NCT00620165 is a clinical study titled "Efficacy of Levetiracetam in Essential Tremor". Essential tremor poses one of the greatest therapeutic challenges to neurologists. This study will examine the effectiveness of the drug, levetiracetam or keppra, for the treatment of essential tremor.
What is the current status of trial NCT00620165?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 10 participants. The study started on 2005-01. Estimated completion is 2008-03.
What interventions are being tested in trial NCT00620165?
The interventions under investigation include: placebo (DRUG), levetiracetam (DRUG).
Who is sponsoring clinical trial NCT00620165?
This trial is sponsored by Southern California Institute for Research and Education, which has 13 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.